Literature DB >> 19598518

Letters to the editor.

R S Garrison.   

Abstract

Year:  1978        PMID: 19598518      PMCID: PMC2516787     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


× No keyword cloud information.
  13 in total

1.  The use of physostigmine as an antidote in accidental diazepam intoxication.

Authors:  J Di Liberti; M L O'Brien; T Turner
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

2.  Reversal of lorazepam delirium by physostigmine.

Authors:  C D Blitt; W C Petty
Journal:  Anesth Analg       Date:  1975 Sep-Oct       Impact factor: 5.108

3.  Anesthesia for the geriatric patient.

Authors:  E M D'Eramo
Journal:  Anesth Prog       Date:  1977 Sep-Oct

4.  Letter: Physostigmine reversal of sedative drugs.

Authors:  H Rosenberg
Journal:  JAMA       Date:  1974-08-26       Impact factor: 56.272

5.  Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine.

Authors:  J S Burks; J E Walker; B H Rumack; J E Ott
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

6.  Case history number 74: reversal of phenothiazine-induced coma with physostigmine.

Authors:  W Bernards
Journal:  Anesth Analg       Date:  1973 Nov-Dec       Impact factor: 5.108

7.  Reversal of systemic toxic effects of scopolamine with physostigmine salicylate.

Authors:  S E Young; R S Ruiz; J Falletta
Journal:  Am J Ophthalmol       Date:  1971-12       Impact factor: 5.258

8.  Physostigmine treatment of anticholinergic-drug depression in postoperative patients.

Authors:  L T Greene
Journal:  Anesth Analg       Date:  1971 Mar-Apr       Impact factor: 5.108

9.  Physostigmine therapy in acute tricyclic antidepressant poisoning.

Authors:  T L Slovis; J E Ott; D T Teitebaum; W Lipscomb
Journal:  Clin Toxicol       Date:  1971-09       Impact factor: 4.467

10.  Reversal of central anticholinergic syndrome in man by physostigmine.

Authors:  R C Duvoisin; R Katz
Journal:  JAMA       Date:  1968-11-25       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.